tm logo
MYOPEPDYS (VESLETEPLIRSEN) INJECTION
Live/Pending
NOTICE OF ALLOWANCE - ISSUED

issued

on 26 Nov 2024

Last Applicant/ Owned by

215 First Street

Cambridge

MA

02142

Serial Number

98370905 filed on 23rd Jan 2024

Registration Number

N/A

Correspondent Address

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC

Raleigh, NC 27609

UNITED STATES

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

MYOPEPDYS (VESLETEPLIRSEN) INJECTION

Medical services; providing health information Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, centra Read More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Medical services; providing health information


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [041]
Education and Entertainment Services


Medical training and teaching


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98370905

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.15.03 -

Incomplete polygons and polygons made of broken or dotted lines

26.15.09 -

Polygons made of geometric figures, objects, humans, plants or animals

Legal History


Show more

Status DateAction Taken
26th Nov 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01st Oct 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01st Oct 2024PUBLISHED FOR OPPOSITION
11th Sep 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
23rd Aug 2024EXAMINERS AMENDMENT -WRITTEN
23rd Aug 2024EXAMINERS AMENDMENT E-MAILED
23rd Aug 2024APPROVED FOR PUB - PRINCIPAL REGISTER
23rd Aug 2024EXAMINER'S AMENDMENT ENTERED
23rd Aug 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
19th Aug 2024ASSIGNED TO EXAMINER